2725
Acute ocular ischemic change may be associated with intravitreal injection of bevacizumab in patients with vascular compromised diabetic retinopathy and/or underlying stenosis of the carotid artery.
 patients with vascular compromised diabetic retinopathy and/or underlying stenosis of the carotid artery: Subject; vascular compromised diabetic retinopathy: Subject.Disorder; underlying stenosis of the carotid artery: Subject.Disorder; Acute ocular ischemic change: Effect; intravitreal injection of bevacizumab: Treatment; bevacizumab: Treatment.Drug; intravitreal injection: Treatment.Dosage
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 patients with vascular compromised diabetic retinopathy and/or underlying stenosis of the carotid artery: Subject; vascular compromised diabetic retinopathy: Subject.Disorder; underlying stenosis of the carotid artery: Subject.Disorder; Acute ocular ischemic change: Effect; intravitreal injection of bevacizumab: Treatment; bevacizumab: Treatment.Drug; intravitreal injection: Treatment.Dosage